Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myeloma
Francesco Maura, Ciara Louise L. Freeman, Kylee H. Maclachlan…·Kenneth H. Shain
The paper identifies genomic and transcriptional changes in multiple myeloma cells that drive resistance to anti-BCMA therapies, termed 'plasma cell identity escape'.